Samsung Medison, a clinical tool system of Samsung Electronic devices that concentrates on establishing analysis imaging tools, stated on Wednesday it intends to acquire Sonio, a Paris-based start-up that makes AI-powered software application for ultrasound process, for about $92.7 million (KRW 126 billion).
The French start-up’s AI aide is targeted at assisting obstetricians and gynecologists with the analysis and documents of ultrasound tests, and it has actually likewise obtained governing clearance in the USA (FDA 510( k)) for Sonio Detect, an item that utilizes deep knowing formulas to boost the picture high quality of ultrasound scans in genuine time.
Samsung Medison stated Sonio’s software application would certainly assist it bring much better AI-driven imaging process to the marketplace. Samsung Electronic devices, which has a 68.45% risk in the clinical tool system, obtained Medison for $22 million in 2011.
Samsung stated in a declaration that complying with the procurement, Sonio will certainly stay an independent business and remain to expand readily and use product or services in France.
Co-founded by Cecile Brosset (CHIEF EXECUTIVE OFFICER) and Remi Besson (CSO) in 2020, Sonio most lately protected $14 million in a Series A led by Cross Border Impact Ventures in August 2023. The business has actually elevated an overall of $27.2 million, according to Tracxn, and its capitalists consist of Elaia, Bpifrance French Technology Seed, OneRagtime, and a couple of angel capitalists.
” Via the procurement of Sonio, Samsung Medison will certainly remain to supply upon our assurance to boost the high quality of individuals’s lives with innovation,” stated Yong Kwan Kim, Chief Executive Officer of Samsung Medison. “Cooperation with Sonio will certainly unite best-in-class ultrasound AI innovation and reporting capacities to bring a standard change in the prenatal ultrasound test.”
” Samsung Medison’s well established worldwide ultrasound service incorporated with Sonio’s innovative AI produces an interesting development chance for both sides,” stated Brosset, chief executive officer of Sonio. “We have actually located in Samsung Medison a fantastic, relying on companion to seek and increase our roadmap and objective. Along with shut partnership with Samsung Medison, as an independent business, Sonio will certainly remain to progress clinical reporting innovation and analysis software application internationally, consisting of for underserved locations in health care.”
